Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
As a barrier against environmental aggressors, microbes, and irritants, this structure aids in preventing transepidermal water loss (TEWL)
V sao li c nhiu ngi a chung trong vic chm sc sc khe v sc p
R.SharpeA.McGregorL.BekkaouiD.et al
Flaherty 1 , Hongmei Mo 1 , Namiki Izumi 5 , Maria Buti 6 , Dr Shalimar 7 and Young-Suk Lim 8 , (1)Gilead Sciences, Inc., (2)Chinese University of Hong Kong, Hong Kong, China, (3)Beaujon Hospital, (4)NYU Grossman School of Medicine, (5)Department of Gastroenterology and Hepatology, Japanese Red Cross Musashino Hospital, (6)Hospital Universitario Vall D'hebron and Ciberehd Del Instituto Carlos III, (7)All India Institute of Medical Sciences, New Delhi, (8)Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South) Background: Tenofovir alafenamide (TAF) has shown similar efficacy and improved safety profiles for treatment of patients with chronic hepatitis B (CHB) compared to tenofovir disoproxil fumarate (TDF)
A Theoretical Approach
US$ 20.77
US$ 25.09
US$ 26.89
US$ 23.02
US$ 20.84
